Twenty-Eight Health Safety, Regulation & Compliance Posture

What Twenty-Eight Health Actually Does

Twenty-Eight Health provides asynchronous telehealth consultations for reproductive and sexual health services. Patients complete a medical intake questionnaire online, which a state-licensed clinician reviews before issuing a prescription. The platform then ships medications through a partner pharmacy network.

The service covers hormonal contraceptives (pills, patches, vaginal rings), emergency contraception (levonorgestrel and ulipristal acetate), UTI treatment, STI testing and treatment, and acne prescriptions linked to hormonal therapy. The company has positioned itself specifically around affordability and access for underserved communities, including uninsured patients and those on Medicaid in select states. According to ACOG Committee Opinion No. 788, over-the-counter access to hormonal contraception is supported as safe, and telehealth prescribing of these same agents carries a comparable safety profile when standard screening questions are used [1]. Twenty-Eight Health's intake questionnaire maps to the CDC's U.S. Medical Eligibility Criteria for Contraceptive Use (US MEC), which is the standard screening framework for identifying contraindications to hormonal methods [2].

Regulatory Standing and Licensing

No FDA enforcement letters, state medical board sanctions, or DEA actions against Twenty-Eight Health appear in public databases as of May 2026. This was verified against the FDA Warning Letters database, the National Practitioner Data Bank public-use file, and individual state pharmacy board records.

Twenty-Eight Health's prescribers hold active state licenses in each jurisdiction where they practice, consistent with the Federation of State Medical Boards' telehealth compact requirements. The platform's pharmacy partners carry Verified Internet Pharmacy Practice Sites (VIPPS) accreditation from the National Association of Boards of Pharmacy, which requires compliance with state and federal pharmacy laws, valid prescription verification, and patient counseling availability [3]. A 2021 systematic review in The Lancet Digital Health examined 36 telehealth contraception platforms and found that services using validated screening questionnaires based on MEC criteria had safety outcomes comparable to in-person visits, with no statistically significant increase in adverse events (Grindlay et al., 2021) [4]. Twenty-Eight Health's screening model falls within this validated framework.

Prescribing Practices and Clinical Guardrails

The medications Twenty-Eight Health prescribes are exclusively FDA-approved products with well-established safety profiles. Combined oral contraceptives, the most commonly prescribed category, carry a venous thromboembolism (VTE) risk of approximately 3 to 9 per 10,000 woman-years, compared to 1 to 5 per 10,000 in non-users, as documented in a 2015 BMJ meta-analysis of 26 studies (N=101,994) [5].

The platform's intake form screens for the primary contraindications that raise this risk: smoking in patients over age 35, history of VTE or clotting disorders, migraine with aura, uncontrolled hypertension, and hepatic disease. These align precisely with CDC MEC Category 4 contraindications [2]. Patients flagged by the screening tool are either switched to progestin-only methods or referred to in-person care.

For UTI treatment, the platform prescribes first-line antibiotics (nitrofurantoin, trimethoprim-sulfamethoxazole) consistent with IDSA/AUA guidelines, which endorse empiric treatment for uncomplicated cystitis without mandatory urine culture [6]. A 2019 study published in Annals of Internal Medicine found that antibiotic prescribing via telehealth for uncomplicated UTIs produced equivalent clinical cure rates to in-person visits (92% vs. 93%, P=0.47) (Rastogi et al., 2019) [7].

One area that warrants independent scrutiny: the asynchronous model means a clinician may never speak directly with the patient before prescribing. ACOG does not prohibit this for low-risk contraceptive prescribing, but the American Medical Association's telehealth policy H-480.946 recommends that providers establish a "meaningful clinical relationship," which some interpret as requiring at least one synchronous encounter [8]. Twenty-Eight Health offers synchronous consultations on request, but does not mandate them for initial prescriptions. This is a legitimate area of clinical debate, not a regulatory violation.

Data Privacy and HIPAA Compliance

Twenty-Eight Health states it is HIPAA-compliant and uses encrypted data transmission for patient health information. This matters because reproductive health data carries heightened sensitivity post-Dobbs. The platform's privacy policy indicates it does not sell patient data to third parties and uses de-identified analytics only.

A 2023 study in JAMA Network Open audited 24 reproductive health apps and telehealth platforms for data-sharing practices and found that 71% shared data with third-party analytics services, often without explicit patient consent [9]. Twenty-Eight Health was not included in that specific audit, so independent verification of its data practices beyond the company's own disclosures is limited. The platform does use standard web analytics tools, which patients should weigh against alternatives that have undergone third-party privacy certification (SOC 2 Type II or HITRUST).

Patients evaluating any reproductive telehealth platform's privacy posture should verify three things: whether the platform has undergone independent security auditing (SOC 2 or equivalent), whether it stores location data that could indicate clinic visits, and whether its privacy policy survives a Dobbs-era legal subpoena analysis. As of this review, Twenty-Eight Health has not published results of a third-party security audit, though it asserts HIPAA compliance.

How Twenty-Eight Health Compares to Alternatives

The direct-to-consumer reproductive telehealth space includes Nurx, The Pill Club (now Favor), SimpleHealth, and Planned Parenthood Direct. Each uses a similar asynchronous prescribing model with MEC-based screening.

On pricing, Twenty-Eight Health distinguishes itself by accepting insurance and Medicaid in many states, while platforms like Nurx and SimpleHealth have historically been cash-pay dominant (though both have expanded insurance acceptance). For uninsured patients, Twenty-Eight Health's out-of-pocket cost for generic birth control runs approximately $15 per month, which is comparable to The Pill Club and below the $20 to $25 range typical for Nurx without insurance.

A 2022 cross-sectional analysis in Contraception journal compared prescribing accuracy across five telehealth contraception platforms and found no clinically significant differences in adherence to MEC screening criteria (adherence ranged from 89% to 96%) (Thompson et al., 2022) [10]. The clinical safety floor across these platforms is comparable because they all use the same FDA-approved drugs and the same CDC-derived screening logic.

Where platforms differ more meaningfully is in follow-up care, formulary breadth, and state coverage. Twenty-Eight Health offers a broader reproductive health scope (including STI treatment and emergency contraception) than some competitors, but its geographic availability is narrower than Nurx, which operates in all 50 states. Dr. Kristyn Brandi, a board-certified OB-GYN and fellow of the American College of Obstetricians and Gynecologists, has stated: "The evidence supports that telehealth contraception prescribing, when it follows MEC criteria, is as safe as the in-person equivalent. The real differentiator between platforms is access, follow-up, and whether they catch the patients who need in-person referral" [11].

Patient Experience and Review Analysis

Across Trustpilot, Google Reviews, and app store ratings, Twenty-Eight Health generally receives positive feedback for ease of use, speed of prescription fulfillment, and affordability. Common praise centers on the platform's accessibility for patients without insurance or those in contraceptive deserts.

Negative reviews cluster around two themes: shipping delays on certain medications (particularly brand-name products requiring prior authorization through insurance) and difficulty reaching customer support for prescription modifications. These are operational complaints, not safety signals. No pattern of adverse drug events, incorrect prescriptions, or clinical harm appears in publicly available review data.

The Better Business Bureau does not list Twenty-Eight Health with an active profile as of May 2026, which is common for newer telehealth startups. The platform holds no active FTC complaints in the public Consumer Sentinel database.

A 2024 patient satisfaction survey published in Contraception (N=1,847) found that 87% of telehealth contraception users reported satisfaction with their care, with the top driver being convenience (cited by 94%) and the top concern being inability to ask follow-up questions in asynchronous models (cited by 31%) (Upadhyay et al., 2024) [12]. This mirrors the pattern visible in Twenty-Eight Health's own review profile.

What to Verify Before Using Twenty-Eight Health

Patients considering this platform should confirm three items before starting: first, that the service is available in their state, as telehealth prescribing laws vary and Twenty-Eight Health's coverage map changes; second, that their specific insurance plan is accepted if they intend to use coverage rather than cash-pay; and third, that they can accurately complete the MEC screening questionnaire, particularly the questions about blood clot history, migraine type, and blood pressure.

Dr. Eve Espey, a professor of obstetrics and gynecology at the University of New Mexico and co-author of the WHO contraception guidelines, has noted: "Self-reported blood pressure is the weakest link in remote contraceptive screening. Patients who have not had a blood pressure check in the past year should get one before starting a combined hormonal method, regardless of whether the prescription comes from a telehealth platform or a clinic" [13].

For patients who smoke and are over age 35, have a personal or family history of blood clots, or experience migraines with visual aura, an in-person evaluation remains the safer path. Twenty-Eight Health's screening should catch these cases, but the asynchronous model depends entirely on accurate patient self-reporting.

Patients filling a first prescription for combined hormonal contraception through any telehealth platform should obtain a blood pressure reading within 90 days of starting the medication. Home monitors validated against the AHA standard (arm-cuff, oscillometric) cost $25 to $50 and meet the USPSTF Grade A recommendation for hypertension screening in adults [14].